Purinoreceptors are involved in the control of acute morphine withdrawal.
The effects exerted by P1 and P2 purinoceptor agonists and antagonists on the acute opiate withdrawal induced by morphine were investigated in vitro. Following a 4 min in vitro exposure to morphine, the guinea-pig isolated ileum exhibited a strong contracture after the addition of naloxone. The P1 purinoceptor agonist, adenosine, was able dose-dependently to reduce morphine withdrawal whereas alpha,beta-methylene ATP (APCPP), a P2 purinoceptor agonist, increased morphine withdrawal. Caffeine, a P1 purinoceptor antagonist, was able significantly and in a concentration dependent manner to increase morphine withdrawal whereas quinidine, a P2 receptor antagonist, reduced it. The results of our experiments indicate that both P1 and P2 purinoceptor agonists and antagonists are able to influence opiate withdrawal in vitro, suggesting an important functional interaction between the purinergic system and opioid withdrawal.
Capasso
A
A
Department of Pharmaceutical Sciences, University of Salerno, Italia. annacap@unisa.it
Loizzo
A
A
D000818:Animals; D006168:Guinea Pigs; D008297:Male; D009020:Morphine / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000502:physiology*; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D018048:Receptors, Purinergic P2 / Q000502:physiology*; D015398:Signal Transduction; D013375:Substance Withdrawal Syndrome
D017450:Receptors, Opioid, mu; D018047:Receptors, Purinergic P1; D018048:Receptors, Purinergic P2; D009020:Morphine